ArticleJournal of translational medicine2025

A novel palmitoylation-based molecular signature reveals COX6A1 as a key regulator in metabolic dysfunction-associated steatotic liver disease.

Tianqi Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.